Partillion Nanovials to Support $2.5M CIRM-Funded Study of CAR T Cell PotencyUSC-led research will combine high-dimensional flow cytometry with Nanovial-based Cell-Cell-seq to study how individual CAR T cells respond when they encounter their targets
